Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Eris Lifesciences falls after Croatia regulator flags issues at Gujarat units

** Shares of Eris Lifesciences ERIS.NS fall 4.5% to 1,368.10 rupees

** Company said Croatia's medicines regulator flagged non-compliance observations at its subsidiary Swiss Parenterals' Unit-1 and Unit-2 injectables facilities in Ahmedabad, Gujarat

** Says observations are procedural, remediation underway

** May delay commercialisation of EU-CDMO product pipeline, co says; adds, minimal impact expected on existing business

** ERIS rated "buy" on average by 10 analysts, median PT 1,773 rupees - data compiled by LSEG

** YTD, stock down about 5%

(Reporting by Surbhi Misra in Bengaluru)

((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))

Recent news on Eris Lifesciences

See all news